Home > Healthcare > Medical Devices > Diagnostic Devices > Cerebral Oximetry Monitoring Market

Cerebral Oximetry Monitoring Market Trends

  • Report ID: GMI6544
  • Published Date: Aug 2023
  • Report Format: PDF

Cerebral Oximetry Monitoring Market Trends

Increasing prevalence of neurological disorders is anticipated to drive the market demand. Cerebral oximetry is a non-invasive monitoring technique that measures regional oxygen saturation (rSO2) in the brain. It is commonly used during surgeries, especially cardiac and vascular procedures, to monitor and optimize cerebral oxygen levels. Neurological disorders and conditions such as stroke, traumatic brain injury, and other neurosurgical interventions often necessitate continuous monitoring of cerebral oxygenation levels to minimize the risk of brain damage.
 

For instance, according to the CDC data, in 2021, over 223,135 people in the U.S. were estimated to be hospitalized due to traumatic brain injury and accounting around 69,473 deaths. As these disorders can have severe consequences on brain health, there is a growing demand for cerebral oximetry monitoring  for traumatic brain injury assessment and optimize brain oxygenation during medical interventions and surgeries. The aging population, sedentary lifestyles, and other lifestyle-related factors contribute to the rise in neurological conditions.
 

Cerebral oximetry monitoring is particularly crucial during surgical procedures that involve risks to brain perfusion, such as cardiac surgeries, vascular surgeries, and neurosurgery. Monitoring cerebral oxygen levels during these procedures allows healthcare providers to make real-time adjustments to maintain adequate brain perfusion, reducing the risk of post-operative neurological complications. The increasing number of surgical procedures globally further drives the demand for cerebral oximetry monitoring systems. Ongoing advancements in medical technology have led to the development of more advanced and user-friendly cerebral oximetry monitoring devices. These devices offer improved accuracy, reliability, and ease of use, making them more attractive to healthcare facilities. As technology continues to evolve, newer and more sophisticated devices are likely to be introduced, further stimulating market share.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Cerebral oximetry monitoring industry value was around USD 205.6 million in 2022 and will reach over USD 410.7 million by 2032.

The cardiac surgery dominated the cerebral oximetry monitoring industry with over 51% share in 2022 as these surgeries, including cardiopulmonary bypass, can increase the risk of oxygen deprivation and ischemia in the brain due to altered blood flow.

North America cerebral oximetry monitoring market size was USD 85.6 million in 2022 and will grow significantly through 2032 owing to the presence of significant industry players, an increase in the number of patients suffering from neurological disorders, an expanding elderly population.

Edwards Lifesciences Corporation, GE Healthcare, Hamamatsu Photonics K.K., ISS, Inc., Masimo Corporation, Medtronic plc, Mespere LifeSciences, Mindray Medical International Ltd., Nihon Kohden Corporation, Nonin Medical, Inc., Sentec AG, Terumo Cardiovascular Systems Corporation among others.

Cerebral Oximetry Monitoring Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 209
  • Countries covered: 18
  • Pages: 145
 Download Free Sample